Prostate Neoplasms Completed Phase 3 Trials for Dutasteride (DB01126)

Also known as: Neoplasm, Prostate / Neoplasms, Prostate / Prostate Neoplasm

IndicationStatusPhase
DBCOND0031071 (Prostate Neoplasms)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00056407REDUCE - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased RiskPrevention